Vitamin D and autoimmunity: new aetiological and therapeutic considerations
- PMID: 17557889
- PMCID: PMC1955167
- DOI: 10.1136/ard.2007.069831
Vitamin D and autoimmunity: new aetiological and therapeutic considerations
Abstract
Vitamin D is frequently prescribed by rheumatologists to prevent and treat osteoporosis. Several observations have shown that vitamin D inhibits proinflammatory processes by suppressing the enhanced activity of immune cells that take part in the autoimmune reaction. Moreover, recent evidence strongly suggests that vitamin D supplementation may be therapeutically beneficial, particularly for Th1-mediated autoimmune disorders. Some reports imply that vitamin D may even be preventive in certain disorders such as multiple sclerosis and diabetes type 1. It seems that vitamin D has crossed the boundaries of calcium metabolism and has become a significant factor in a number of physiological functions, specifically as a biological inhibitor of inflammatory hyperactivity.
Conflict of interest statement
Competing interests: None.
References
-
- Harel M, Shoenfeld Y. Predicting and preventing autoimmunity, myth or reality? Ann NY Acad Sci 20061069322–345. - PubMed
-
- Van Etten E, Branisteanu D D, Overbergh L, Bouillon R, Verstuyf A, Mathieu C. Combination of a 1,25‐dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone. Bone 200332397–404. - PubMed
-
- Cantorna M T, Hayes C E, DeLuca H F. 1,25‐Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 199812868–72. - PubMed
-
- Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 199437552–558. - PubMed